Screener
Relay Therapeutics, Inc. RLAY Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
FAQ
- What is Relay Therapeutics, Inc.'s invested capital?
- Relay Therapeutics, Inc. (RLAY) reported invested capital of $799.48M in Q2 2026.
- How has Relay Therapeutics, Inc.'s invested capital changed year-over-year?
- Relay Therapeutics, Inc.'s invested capital increased by 36.5% year-over-year, from $585.9M to $799.48M.
- What is the long-term trend for Relay Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s invested capital has grown at a 8.7% compound annual growth rate (CAGR), from $340.07M to $515.5M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Relay Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude